BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELVT
3951
DELISTED
Elevate Credit, Inc.
ELVT
| $14.2K | ﹤0.01% |
3,370
+582
| +21% | +$2.58K |
|
3952
Greene County Bancorp
GCBC
$595M
| $14.1K | ﹤0.01% |
1,028
+328
| +47% | +$4.5K |
|
|
OTRK
3953
DELISTED
Ontrak
OTRK
| $14.1K | ﹤0.01% |
+10
| New | +$15.1K |
|
3954
AstroNova
ALOT
$227M
| $14.1K | ﹤0.01% |
869
+851
| +4,728% | +$17.8K |
|
|
AC
3955
DELISTED
Associated Capital Group
AC
| $14K | ﹤0.01% |
395
-81
| -17% | -$2.95K |
|
|
EVLO
3956
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $14K | ﹤0.01% |
115
+6
| +6% | +$825 |
|
3957
Information Services Group
III
$250M
| $14K | ﹤0.01% |
5,625
+5
| +0.1% | +$13 |
|
3958
Crawford & Co Class B
CRD.B
$585M
| $13.8K | ﹤0.01% |
1,366
| – | – |
|
3959
Marchex
MCHX
$80.6M
| $13.8K | ﹤0.01% |
4,379
+2,732
| +166% | +$10.5K |
|
|
AKRO
3960
DELISTED
Akero Therapeutics
AKRO
| $13.7K | ﹤0.01% |
+604
| New | +$14.1K |
|
3961
Airgain
AIRG
$67.7M
| $13.7K | ﹤0.01% |
1,168
+1,144
| +4,767% | +$14.2K |
|
3962
Genie Energy
GNE
$386M
| $13.6K | ﹤0.01% |
1,823
+1,393
| +324% | +$12.2K |
|
3963
Celsius Holdings
CELH
$7.28B
| $13.5K | ﹤0.01% |
11,682
+3,651
| +45% | +$5.08K |
|
3964
X4 Pharmaceuticals
XFOR
$425M
| $13.5K | ﹤0.01% |
35
+32
| +1,067% | +$12.7K |
|
3965
CALL
Toyota
TM
$223B
| $13.4K | ﹤0.01% |
1
-18
| -95% | -$2.36K |
|
|
AVDR
3966
DELISTED
Avedro, Inc Common Stock
AVDR
| $13.3K | ﹤0.01% |
588
+575
| +4,423% | +$12.5K |
|
3967
iRadimed
IRMD
$1.11B
| $13.3K | ﹤0.01% |
634
+218
| +52% | +$4.45K |
|
|
TBCH
3968
Turtle Beach Corp
TBCH
$230M
| $13.3K | ﹤0.01% |
1,142
-13
| -1% | -$129 |
|
|
SRT
3969
DELISTED
Startek Inc.
SRT
| $13.3K | ﹤0.01% |
2,057
+1,276
| +163% | +$8.64K |
|
3970
Sonida Senior Living
SNDA
$1.88B
| $13.3K | ﹤0.01% |
202
| – | – |
|
|
FTSI
3971
DELISTED
FTS International, Inc. Common Stock
FTSI
| $13.1K | ﹤0.01% |
293
+33
| +13% | +$2.37K |
|
|
AXAS
3972
DELISTED
Abraxas Petroleum Corp
AXAS
| $13.1K | ﹤0.01% |
1,288
-3
| -0.2% | -$42 |
|
3973
Savara
SVRA
$1.08B
| $12.6K | ﹤0.01% |
4,758
+1,547
| +48% | +$3.87K |
|
|
ASRT
3974
DELISTED
Assertio
ASRT
| $12.6K | ﹤0.01% |
164
+52
| +46% | +$6.77K |
|
|
MBII
3975
DELISTED
Marrone Bio Innovations, Inc.
MBII
| $12.5K | ﹤0.01% |
8,897
+2,527
| +40% | +$3.57K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.